ScreenerHero

NANOFS Nanoform Finland Oyj

Partial data
STO · SE · Healthcare · Biotechnology · nanoform.com
10.12SEK0.00%Mkt Cap: 83.01M $P/E: —

Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies,…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.24BUSDP/E 29.3
REGN
Regeneron Pharmaceuticals, Inc.
$76.05BUSDP/E 18.3
MRNA
Moderna, Inc.
$74.84BUSD
ARGX
argenx SE
$56.77BUSDP/E 37.1
ARGX
argenx SE
$58.21BUSDP/E 35.5
UCB
UCB SA
$41.93BUSDP/E 17.9
RVMD
Revolution Medicines, Inc.
$42.84BUSD
ONC
BeOne Medicines AG
$41.27BUSDP/E 64.9
RPRX
Royalty Pharma plc
$32.61BUSDP/E 30.0
ALNY
Alnylam Pharmaceuticals, Inc.
$29.97BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.66BUSD
BNTX
BioNTech SE
$24.05BUSD
GMAB
Genmab A/S
$23.24BUSDP/E 29.8
INSM
Insmed Incorporated
$22.98BUSD
GMAB
Genmab A/S
$22.23BUSDP/E 30.6
INCY
Incyte Corporation
$22.85BUSDP/E 14.4
JAZZ
Jazz Pharmaceuticals plc
$15.02BUSDP/E 15.9
ASND
Ascendis Pharma A/S
$14.87BUSDP/E 17.3
EXEL
Exelixis, Inc.
$14.45BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$13.81BUSD

Key Statistics

Company
Market Cap83.01M USD
Enterprise Value92.19M USD
Revenue (TTM)495.86K USD
Gross Profit291.07K USD
Net Income (TTM)-1.71M USD
Revenue/Share0.06 SEK
Last Price10.12 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees171
CountrySE
SectorHealthcare
IndustryBiotechnology
ISINFI4000330972
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-66.22
EV/Revenue185.93
P/S173.03
P/B22.54
EPS (TTM)-1.76
EPS (Forward)—
52W Range
10.026% of range11.70
52W High11.70 SEK
52W Low10.02 SEK
Profitability
Gross Margin85.82%
Oper. Margin-399.03%
EBITDA Margin-280.79%
Profit Margin-504.74%
ROE-41.84%
ROA-33.16%
Growth
Revenue Growth39.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.69M USD
CapEx (TTM)108.76K USD
FCF Margin-151.85%
FCF Yield-0.91%
Net Debt-1.21M USD
Net Debt/EBITDA0.87
Balance Sheet
Debt/Equity0.15
Current Ratio3.12
Quick Ratio2.93
Book Value/Sh0.46 SEK
Cash/Share0.20 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.85.75M
Float26.80M
Insiders23.28%
Institutions38.27%
Technical
SMA 509.556 (+5.9%)
SMA 2008.980 (+12.7%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)9.28K
Avg Vol (10d)8.75K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—